Paul Holt Net Worth

The estimated Net Worth of Paul Holt is at least $94 ezer dollars as of 7 June 2018. Paul Holt owns over 14,207 units of NantHealth Inc stock worth over $94,034 and over the last 8 years Paul sold NH stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Paul Holt NH stock SEC Form 4 insiders trading

Paul has made over 4 trades of the NantHealth Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Paul exercised 14,207 units of NH stock worth $19,179 on 7 June 2018.

The largest trade Paul's ever made was exercising 72,727 units of NantHealth Inc stock on 7 June 2016 worth over $98,181. On average, Paul trades about 27,272 units every 183 days since 2016. As of 7 June 2018 Paul still owns at least 69,655 units of NantHealth Inc stock.

You can see the complete history of Paul Holt stock trades at the bottom of the page.

What's Paul Holt's mailing address?

Paul's mailing address filed with the SEC is C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY, CA, 90232.

Insiders trading at NantHealth Inc

Over the last 8 years, insiders at NantHealth Inc have traded over $296,800 worth of NantHealth Inc stock and bought 18,682,506 units worth $35,921,893 . The most active insiders traders include Patrickcalifornia Capital E..., Patrick Cambridge Equities,... és Patrick Soon Shiong. On average, NantHealth Inc executives and independent directors trade stock every 220 days with the average trade being worth of $2,141,564. The most recent stock trade was executed by Patrickcalifornia Capital E... on 28 August 2023, trading 15,921,888 units of NH stock currently worth $15,921,888.

What does NantHealth Inc do?

nanthealth is a next-generation, personalized healthcare company enabling more effective treatment decisions for critical illnesses and improved patient outcomes. our unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale biometric and phenotypic data to truly deliver precision medicine. our mission: optimize patient outcomes and enable value based care through advancements in technology and precision medicine. for more information please visit www.nanthealth.com and follow us on twitter @nanthealth.

Complete history of Paul Holt stock trades at NantHealth Inc

NantHealth Inc executives and stock owners

NantHealth Inc executives and other stock owners filed with the SEC include:

• Ronald Allen Louks,
  Chief Operating Officer
• Bob Petrou,
  Chief Financial Officer
• Dr. Patrick Soon-Shiong F.A.C.S., FACS, FRCS (C), M.Sc.,
  Founder, Chairman & CEO
• Dr. Patrick Soon-Shiong F.A.C.S., M.Sc., FRCS (C), M.D., FACS,
  Founder, Chairman & CEO
• Dinesh Swamy,
  Non-Executive Independent Director
• B. Subramanya,
  Non-Executive Independent Director
• Arun Seth,
  Non-Executive Independent Director
• Nivruti Rai,
  Additional Non-Executive Independent Director
• Manohar Chatlani,
  Non-Executive Independent Director
• Muthuraman Balasubramanian,
  Non-Executive Independent Director
• Kiran Shaw,
  Non-Executive Director
• Deepak Venugopalan,
  Zonal Director
• Vijay Singh,
  Zonal Director
• Srikanth Raman,
  Heads - Internal Audit Division
• Karthik Ramakrishnan,
  Head of Business Development
• Arunesh Punetha,
  Zonal Director
• Hanuman Prasad,
  Zonal Director
• Sunil C. N.,
  Zonal Director
• Nitin Barekere,
  Group Head of Human Resources
• Viren Shetty,
  Whole Time Director
• Sridhar S,
  Group Company Secretary, Legal and Compliance Officer
• Sumanta Ray,
  Chief Marketing Officer
• Ravichandran Natarajan,
  Senior Vice-President and Head of Corporate Relations and CSR
• Nagarajan Anantharaman,
  Senior Vice President - Finance
• Kesavan Venugopalan,
  Chief Financial Officer
• Emmanuel Rupert,
  Group Chief Executive Officer, Managing Director
• Devi Shetty,
  Executive Chairman of the Board
• Dr. Tiffany Avery,
  Chief Medical Officer
• Arlyn R. Small Jr.,
  Sr. VP of HR
• Jerry Magin,
  Sr. VP of Global Sales & Marketing
• Dr. Stephen Benz,
  Sr. VP of Machine Learning & Research
• Chris House,
  Sr. VP of Product Management & Devel.
• Keith Krebs,
  Sr. VP of Client Services
• Dr. Sandeep K. Reddy,
  Chief Medical Officer
• Maureen Becker,
  Sr. VP of HR
• Mark Mozley,
  Sr. VP of Global Sales & Marketing
• Brandon Villery,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Bob Petrou,
  Chief Financial Officer
• Healthcare Solutions Inc Al...,
  10% owner
• Patrick Cambridge Equities,...,
  Chairman and CEO
• James Mark Burnett,
  Director
• Paul Holt,
  Chief Financial Officer
• Patrickcalifornia Capital E...,
  Chief Executive Officer
• Michael D Blaszyk,
  Director
• Kirk K Calhoun,
  Director
• Michael S Sitrick,
  Director
• Patrickcalifornia Capital E...,
  Chief Executive Officer
• Deanna L. Wise,
  Director
• Ronald Allen Louks,
  Chief Operating Officer
• Patrickcalifornia Capital E...,
  Chairman and CEO
• Patrick Soon Shiong,
  Chairman and CEO
• Patrickcalifornia Capital E...,
  Chief Executive Officer